Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024
Fulgent Genetics (NASDAQ: FLGT) will announce its second quarter 2024 financial results on Friday, August 2, 2024, before the market opens.
The company will host a conference call for investors at 8:30 AM ET (5:30 AM PT) on the same day to discuss the results and answer questions.
The live audio webcast and replay will be accessible on Fulgent's Investor Relations website.
- None.
- None.
The call may be accessed through a live audio webcast on the Investor Relations section of the Company’s website, http://ir.fulgentgenetics.com. An audio replay will be available at the same location.
About Fulgent
Fulgent is a technology-based company with a well-established laboratory services business and a therapeutic development business. Fulgent’s laboratory services business, which was formerly referred to as the clinical diagnostic business, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Fulgent’s therapeutic development business is focused on developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The Company aims to transform from a genomic diagnostic business into a fully integrated precision medicine company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240711032786/en/
Investor Relations Contact:
The Blueshirt Group
Melanie Solomon, melanie@blueshirtgroup.com
Source: Fulgent Genetics, Inc.
FAQ
When will Fulgent Genetics announce its Q2 2024 financial results?
How can I access Fulgent Genetics' Q2 2024 financial results conference call?
What time is the Fulgent Genetics Q2 2024 financial results conference call?